Delivery Order SPE2DB24D2205-SPE2DB25FEHPW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Chloraseptic Max 15-10 mg lozenges in quantities of 15 units. This is a firm fixed-price delivery order with a ceiling value of $2,636.76 and an ultimate completion date of August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,707.30 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages). Issued on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $5,290.15 delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15 count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in supplying...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-count) under a firm fixed-price contract valued at $3,864.64, with an ultimate completion date of September 18, 2025. This non-set-aside award was issued competitively and represents a single delivery order for over-the-counter throat lozenges to support federal medical supply needs. The contract was performed at AmerisourceBergen's corporate office location in...
- This $3,041.94 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Chloraseptic Max 15-10 mg lozenge supplies, with a period of performance through November 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $5,855.84 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18 count) on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed price contract, which received no set-aside designation, was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,119.84 for Chloraseptic sore throat lozenges (18-count). This firm fixed-price contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement relationship. The order will be performed in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,795.28 firm fixed-price delivery order is for Chloraseptic Max 15-10 mg Loz 15s, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
- The Defense Logistics Agency awarded a $1,290.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages) on June 2, 2025, with an ultimate completion date of June 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHPWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-count packages) with a ceiling value of $3,021.03. This competitively awarded, non-set-aside contract employs firm fixed price pricing and is scheduled for completion by September 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's significant federal contract portfolio demonstrates its capability to deliver diverse medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/15/25 |